Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

“These drugs may sort of turn down the gain on ... is studying how the oral form of semaglutide, sold under the brand name Rybelsus, may help people with alcohol addiction stop drinking.

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Oral semaglutide is already sold as Rybelsus in a 14 mg formulation for the treatment of type 2 diabetes, bringing in sales of $1.6 billion last year, but extending its use into non-diabetic ...

Although the ad does not identify the medication, Hims & Hers offers compounded versions of the weight-loss drug semaglutide ... The ad shows images of drug while describing the products as ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified pr ...

Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.

The EMA's main advisory committee has backed approval of Novo Nordisk's oral GLP ... also based on semaglutide. The CHMP has issued a positive opinion for the drug as a treatment for adults ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Hims has a great deal of meme potential, which could benefit the company by effectively acting as free advertising. Read more ...